ControversiesChallengesConsensus

About Anthony Strzalek

This author has not yet filled in any details.
So far Anthony Strzalek has created 9 blog entries.

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone

2019-04-30T17:29:51+01:00

Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure balloon. The trial results for the treatment of failing haemodialysis arteriovenous shunts were presented by Qizhuang […]

New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone2019-04-30T17:29:51+01:00

TEVAR performed outside the IFU has “dramatically worse outcomes”

2019-04-18T17:33:06+01:00

Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed a significant increase in mortality […] an increased reintervention rate and four times higher endoleak rate,” […]

TEVAR performed outside the IFU has “dramatically worse outcomes”2019-04-18T17:33:06+01:00

CX 2019: Highlights from the inaugural iWounds Workshop

2019-04-26T11:02:41+01:00

Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.

Edmonds discusses why “too many legs are being lost” and Serena talks […]

CX 2019: Highlights from the inaugural iWounds Workshop2019-04-26T11:02:41+01:00

Don’t miss: The influence of hyperglycaemia on spinal cord injury

2019-04-18T11:39:14+01:00

Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.”

Hiramoto is presenting new research on this topic at the Charing Cross session on Spinal Cord Ischaemia in the Upper […]

Don’t miss: The influence of hyperglycaemia on spinal cord injury2019-04-18T11:39:14+01:00

CX 2019: Why a signed consent form “is not consent”

2019-04-17T20:34:29+01:00

Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for informed consent has changed “dramatically” in recent years which has led to “the death of […]

CX 2019: Why a signed consent form “is not consent”2019-04-17T20:34:29+01:00

News from CX 2019: Evidence supports safety of paclitaxel-coated devices

2019-04-30T17:36:09+01:00

At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in the treatment of peripheral arterial disease patients; examines new evidence on […]

News from CX 2019: Evidence supports safety of paclitaxel-coated devices2019-04-30T17:36:09+01:00

Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data

2019-04-17T11:51:20+01:00

There were several calls at the CX 2019 Highlight Session Paclitaxel: The last word on the need for a meta-analysis of individual patient-level data going forward and greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices.

Cook Medical has just announced the release of de-identifiable […]

Breaking news from CX 2019: Cook leads the way to data transparency with release of long-term ZILVER PTX patient-level data2019-04-17T11:51:20+01:00

Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word

2019-04-17T09:48:40+01:00

Elena Ladich (Hollywood, USA) and Roger Greenhalgh (London, UK) discuss the current uncertainty surrounding the use of paclitaxel devices and the need for individual patient-level data analyses going forward to better understand the mortality signal raised by the Katsanos et al meta-analysis.

Ladich believes that “we need to take a step […]

Key take-aways from the CX 2019 Highlight Session on Paclitaxel: The Last Word2019-04-17T09:48:40+01:00

CX 2019: Stroke following cardiac surgery is a “wake-up call”; safety of carotid stenting debate

2019-04-16T17:04:52+01:00

In the Acute Stroke Challenges session on Monday, Nick Hopkins talks to CX Live about the “significant increase” of incidents of stroke following cardiac surgery which is “much more common than previously thought”.

Ross Naylor and Peter Schneider debated the impact of new technologies and innovations […]

CX 2019: Stroke following cardiac surgery is a “wake-up call”; safety of carotid stenting debate2019-04-16T17:04:52+01:00